NCT00533416View on ClinicalTrials.gov

Safety of ON 01910.Na in Patients With Myelodysplasia

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 14, 2007

Primary Completion Date

June 4, 2012

Study Completion Date

June 4, 2012

Conditions
Myelodysplastic Syndrome (MDS)
Interventions
DRUG

ON 01910 Na

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00533416 - Safety of ON 01910.Na in Patients With Myelodysplasia | Biotech Hunter | Biotech Hunter